Preventing nausea from lung cancer chemo-radiation with two drugs
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests two anti-nausea medications, Rolapitant and Palonosetron, to see how well they prevent nausea and vomiting in people with lung cancer who are receiving both chemotherapy and radiation. The study aims to help patients manage these side effects better during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with lung cancer.
- You are about to start chemotherapy (with a strong nausea-causing drug) and radiation therapy for at least 6 weeks.
- You have a good performance status (ECOG 0 or 1), meaning you are able to carry out daily activities without much help.
- You do not have brain tumors causing symptoms like severe headache or vomiting, and you haven't been vomiting recently.
- You are not pregnant or breastfeeding, and you have no history of epilepsy or severe allergies to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two medications (fosrolapitant and palonosetron) to prevent severe nausea and vomiting in patients with esophageal or lung cancer who are receiving chemotherapy combined with immunotherapy. If the medications work well, they could help patients feel better during treatment and complete their cancer care more comfortably.
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This trial tests if combining two anti-nausea drugs (olanzapine and palonosetron) can prevent vomiting and nausea without using steroids in people receiving high-dose cisplatin chemotherapy for their first time.
This trial tests whether a combination of two anti-nausea drugs (fosrolapitant and palonosetron) can better prevent nausea and vomiting caused by Trastuzumab Rezetecan. If you are starting this cancer treatment, you may be able to join.
This trial tests a new form of megestrol acetate to prevent nausea and vomiting caused by chemotherapy in people with advanced stomach cancer who haven't had chemo before. It's for those starting a specific chemo combo that includes a PD-1 inhibitor and CAPOX.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.